Acquisition of Consumer Healthcare company Easypharm OTC GmbH strengthens position in … Continue reading “European CNS specialist Neuraxpharm strengthens expansion into Austrian market with acquisition of easypharm”
The proceeds will be used to advance the first MKK4 inhibitor into … Continue reading “Novo Seeds Portfolio Company HepaRegeniX GmbH secures Series B Financing in excess of EUR 11 Million”
IXICO plc (AIM: IXI), the AI data analytics company delivering insights in … Continue reading “IXICO to Present Tau PET Imaging Research at Human Amyloid Imaging Conference”
Primary endpoint met at all doses: ensifentrine produced clinically and statistically significant … Continue reading “Verona Pharma Reports Positive Top-line Data in 4 Week Phase 2b COPD Study with Nebulized Ensifentrine on Top of Tiotropium Therapy”
LONDON, Jan. 10, 2020 – Theragnostics, which is developing molecular radiotherapy for imaging … Continue reading “Theragnostics Expands Team with Significant Appointments”
Strengthened BiOrigin Entrepreneur-in-residence Advisory Unit with seasoned CEOs REPAIR Impact investments now … Continue reading “Novo Seeds Provides Business Update”
LONDON, Jan. 10, 2020 (GLOBE NEWSWIRE) — Verona Pharma plc (AIM: VRP) … Continue reading “Verona Pharma to Report 4 Week Phase 2b COPD Dose-ranging Study Results with Nebulized Ensifentrine on Top of Tiotropium Therapy”
Creates a global leader with first in class molecules for fibrotic disease … Continue reading “Novo Seeds Portfolio Company Galecto Announces Merger with US based PharmAkea”
Creates a global leader with first in class molecules for fibrotic disease … Continue reading “Novo Seeds Portfolio Company Galecto Announces Merger with US based PharmAkea”
Key hires enhance management for next development phase 09 January 2020, Windsor, … Continue reading “Macrophage Pharma Expands Executive Team with Chief Scientific Officer and Chief Technology Officer”
Expansion of Supervisory Board Supports Global Growth Strategy Amsterdam, Netherlands and Hoboken, … Continue reading “Castor Appoints Dr. Ben Cons as Chairman of the Supervisory Board”
– Funds used to complete Phase 2b ICONA study in NASH and … Continue reading “Novo Seeds Portfolio Company NorthSea Therapeutics Raises USD 40 Million Series B Financing”
Syndicate includes leading UK investors Amadeus Capital Partners, Delin Ventures and Kindred … Continue reading “Ori Biotech announces a $9.4M seed round to advance innovation in Cell and Gene Therapy manufacturing”
08 January 2020, London, UK: Optimum Strategic Communications (Optimum), the international strategic … Continue reading “Optimum Strategic Communications Expands Team with Appointment of Shabnam Bashir”
LONDON, Jan. 07, 2020 (GLOBE NEWSWIRE) — Verona Pharma plc (AIM: VRP) … Continue reading “Verona Pharma Appoints David Moskowitz as Vice President, Capital Markets Strategy & Investor Relations”
‒ The Fund has now committed a total of USD 48 million to … Continue reading “Novo Holdings REPAIR Impact Fund Invests USD 12 million in Mutabilis and IBT Vaccines and provides strategic update”
To accelerate development of molecular targeted systemic radiotherapy (SR, PRRT) based on … Continue reading “Edinburgh Molecular Imaging Closes Financing”
Forendo Pharma, a clinical stage drug development company focusing on novel treatments … Continue reading “Forendo Pharma signs important License and Collaboration Deal with Leading Pharma Company”
09 December 2019, Cambridge, UK: STORM Therapeutics, the biotechnology company focused on … Continue reading “STORM Therapeutics’ collaborator awarded ASH–BSH Abstract Achievement Award at the 61st ASH Annual Meeting & Exposition”
For more information about Optimum Strategic Communications, please get in touch
We'd love to hear from you...
GET IN TOUCH
© Copyright 2020 Optimum Strategic Communications All rights reserved.
Warnford Court
29 Throgmorton Street
London
EC2M 4PL
Tel: +44 (0)203 950 9144
Email: contact@optimumcomms.com